India's Bajaj Healthcare hits over 1-yr high on Australian nod for its API plant

Bajaj Healthcare

09/12/2024 05:53

** Shares of pharma co Bajaj Healthcare  BAJH.NS  rise as
much as 4.7% to 451.80 rupees, hitting their highest since Oct
2023; last up 3.6%
    ** Co's active pharmaceutical ingredient (API) manufacturing
site in Gujarat gets approval from Therapeutic Goods
Administration, Australia
    ** Approval for direct supply of API to Australia and New
Zealand
    ** More than 741,000 shares change hand, about five times
the 30-day avg 
    ** Stock up ~19% so far this year vs a ~21% rise in peer
Aarey Drugs and Pharmaceuticals  ADPH.NS  


 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))